Core Viewpoint - H&H International Holdings reported a decline in net profit despite a slight increase in revenue, leading to a drop in share price [1] Financial Performance - The company achieved revenue of RMB 7.019 billion for the six months ending June 30, 2025, representing a year-on-year increase of 4.89% [1] - Net profit attributable to shareholders was RMB 71.017 million, a significant decrease of 76.78% compared to the previous year [1] - Basic earnings per share were reported at RMB 0.11 [1] Dividend Announcement - The company proposed an interim dividend of HKD 0.19 per ordinary share, down from HKD 0.30 in the same period last year [1] Business Segment Performance - Revenue growth was attributed to all business segments, including adult nutrition and care products, infant nutrition and care products, and pet nutrition and care products [1] - The high-margin nutritional supplements across all three business segments saw a year-on-year revenue increase of 4.6%, accounting for 65.6% of total revenue [1]

智通财经APP获悉，H&H国际控股(01112)跌超5%，截至发稿，跌4.82%，报13.23港元，成交额6605.5 万港元。 消息面上，H&H国际控股发布截至2025年6月30日止6个月的中期业绩，该集团取得收入人民币70.19亿 元(单位下同)，同比增加4.89%；母公司拥有人应占溢利7101.7万元，同比减少76.78%；每股基本盈利 0.11元。拟派发中期股息每股普通股0.19港元，上年同期派0.3港元。 公告称，收入增加主要由于所有业务分部(即成人营养及护理用品、婴幼儿营养及护理用品及宠物营养 及护理用品)增长所致。截至2025年6月30日止6个月，集团所有三个业务分部的高利润率营养补充品所 得收入按同类比较基准按年增长4.6%，占集团总收入的65.6%。 ...